• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Model Number VTICM5 12.6 (-5.5/ 2.0)
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 02/13/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H11: manufacturer narrative: secondary surgical intervention to remove/replace/reposition the lens is identified in the labeling as a known potential adverse event following icl implantation.H6: health effect- clinical code: 4581- significant reduction of iridocorneal angles, significant shallowing of ac, and iridocorneal touch.Claim#: (b)(4).
 
Event or Problem Description
A facility representative reported that following an implantable collamer lens (icl) implantation procedure, the patient experienced excessive vault, significant reduction of iridocorneal angles and significant shallowing of ac.Reportedly, 'iridocorneal touch'.In a separate surgery the lens was exchanged with the same model, shorter length and the problem was resolved.The cause of the event was reported as unknown.
 
Additional Manufacturer Narrative
Corrected data: b5.- a facility representative reported that following an implantable collamer lens (icl) implantation procedure, the patient experienced excessive vault, significant reduction of iridocorneal angles, significant shallowing of ac and peripheral anterior synechia.Reportedly, 'iridocorneal touch'.In a separate surgery the lens was exchanged with the same model, shorter length and the problem was resolved.The cause of the event was reported as unknown.H6 - health effect- clinical code: 4581 - significant reduction of iridocorneal angles, significant shallowing of ac, and 'peripheral anterior synechia' should be added.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVO/EVO + VISIAN IMPLANTABLE COLLAMER LENS (ICL)
Common Device Name
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene enriquez
1911 walker avenue
monrovia, CA 91016
MDR Report Key24832368
Report Number2023826-2026-00614
Device Sequence Number16059945
Product Code QCB
UDI-Device Identifier00840311308293
UDI-Public(01)00840311308293(11)230727(17)260630
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P030016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/09/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/30/2026
Device Model NumberVTICM5 12.6 (-5.5/ 2.0)
Device Catalogue NumberVTICM5 12.6
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/07/2026
Supplement Date Received by Manufacturer04/13/2026
07/14/2026
Initial Report FDA Received Date04/09/2026
Supplement Report FDA Received Date04/13/2026
07/14/2026
Date Device Manufactured07/27/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
INJECTOR MODEL: MSI-PF, LOT# UNK
Outcome Attributed to Adverse Event Required Intervention;
Patient Age31 YR
Patient SexFemale
-
-